# FDA Inspection 705728 - Southern Illinois Healthcare Dba Herrin Hospital - January 10, 2011

Source: https://www.keypedia.com/records/fda_inspections/southern-illinois-healthcare-dba-herrin-hospital/769b987a-9544-4400-a4f1-6d222a134628
Source feed: FDA_Inspections

> FDA Inspection 705728 for Southern Illinois Healthcare Dba Herrin Hospital on January 10, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 705728
- Company Name: Southern Illinois Healthcare Dba Herrin Hospital
- Inspection Date: 2011-01-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1122821 - 2020-02-20](https://www.keypedia.com/records/fda_inspections/southern-illinois-healthcare-dba-herrin-hospital/8b2d6863-0be6-4a43-9c8b-83492273cf69)
- [FDA Inspection 985195 - 2016-09-12](https://www.keypedia.com/records/fda_inspections/southern-illinois-healthcare-dba-herrin-hospital/820b67e5-2695-4c60-9685-1fe75bdc097a)
- [FDA Inspection 814565 - 2013-01-17](https://www.keypedia.com/records/fda_inspections/southern-illinois-healthcare-dba-herrin-hospital/3e796027-e9c1-4d08-ac92-773bac61aa78)

Company: https://www.keypedia.com/companies/southern-illinois-healthcare-dba-herrin-hospital/54f3e142-d7a8-400b-92f7-da141cf9c3c9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d